Bone and Joint Tuberculosis in Bamrasnaradura Infectious Disease Institute
Keywords:
Bone and joint tuberculosis Bamrasnaradura Infectoius Diseases InstituteAbstract
The objective of this study were to study the clinical characteristics of bone and joint tuberculosis in HIV-positive and HIV-negative patients and to study predisposing factors and management. A retrospective study of 21 patients with bone and joint tuberculosis attended at Bamrasnaradura Infectious Diseases Institute from March 2002 through July 2006 was done by reviewing medical records in detail. The study group comprised of 13 HIV positive (61.9%) and 8 HIV negative patients (38.1%). The clinical presentation of bone and joint tuberculosis were similar in HIV positive and negative patients. The most important symptom was chronic pain which were presented in all patients, average 22.9±9.1 months in HIV-negative and 9.1± 3.0 months in HIV positive patients. The elderly more than 60 year old was a significant risk factor in HIV negative patients (75% in HIV negative vs. 0% in HIV positive patients who were older than 60 years old, p < 0.001). In HIV positive patients, the history of prior contacted or infected with tuberculosis was a significant risk factor for reactivated extra-pulmonary tuberculous infection in bone and joints (1.3% in HIV negative vs. 62.5% in HIV positive patients, p = 0.027). The CD4 count which was represented the immunologic status of the patients had less effect (46.2% of the HIV positive patients had CD4 level more than 200 cell/mm3). The result of anti-tuberculosis drugs given for at least 12 months was satisfactory. No recurrent infection nor serious complication was found.
Downloads
References
2. World Health Organization (WHO). Global tuberculosis control, WHO report 2002. Available at: http://www.who.int/gtb/publications. Accessed 6 June 2003.
3. Zhenhua Y, Ying K, Frank W, Betsy F, et al. Identification of risk factors for extra-pulmonary tuberculosis. Clin Infect Dis. 2004; 38: 199-205.
4. Leibert E, Schluger N W, Bonk S, Rom W N.Spinal tuberculosis in patients with immunodeficiency virus infection: clinical presentation, therapy and outcome. Tubercle and Lung Dis. 1996; 77: 329-34.
5. Shizad H, Sigrid P, Per Riegels-Nielsen. Bone and joint tuberculosis in Denmark. Acta Orthop Scand 2000; 71(3): 312-15.
6. Shafer R W, Kim D S, Weiss J P, Quale J M. Extra-pulmonary tuberculosis in patients with human immunodeficiency virus infection. Medicine 1991; 70: 384-97.
7. Vohra R, Kang H S, Dogra S, Saggar R R, Sharma R. Tuberculous osteomyelitis. J Bone Joint Surg(Br) 1997; 79-B: 562-66.
8. Belzunegue J, Santisteban M, Gorordo M, Barasay E, et al. Osteoarticular mycobacterial infections in patients with the human immunodeficiency virus. Clin Exp Rheumatol 2004; 22: 343-45
9. Medical Research Council Working Party on Tuberculosis of the Spine, Twelfth Report. Controlled trial of short-course chemotherapy in the ambulatory treatment of spinal tuberculosis. J Bone Joint Srug 1993; 75: 240-248.
10. Perriens J H, St Louis M E, Mukadi Y B, et al. Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months. N Engl J Med 1995; 332: 779-84.
11. American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adultsand children. Am J Respir Crit Care Med 1994; 149: 1359-74.
Downloads
Published
How to Cite
Issue
Section
License
Articles published in the Disease Control Journal are considered as academic work, research or analysis of the personal opinion of the authors, not the opinion of the Thailand Department of Disease Control or editorial team. The authors must be responsible for their articles.